Skip to main content
Kane Biotech
Biofilms
Overview
Understanding Biofilms
coactiv+™
DispersinB
®
Glossary Of Terms
Commercialization Vehicles
Overview
Kane Wound Care & Surgical
Kane Dermatology
About
Overview
Our Team
Careers
Contact
Publications
Blog
Publications / Posters
News / Events
Investors
Overview
News / Events
Company Information
Financial Results
Stock Data
SEDAR
Corporate Governance
Press Releases
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investors
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Overview of Kane Wound Care
DermaKB OTC Shampoo Trials
Presentations
Management Team
Contacts
Financial Results
Stock Data
TSX-V:KNE
OTCQB:KNBIF
SEDAR
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
News / Events
Press Releases
IR Calendar
Email Alerts
All News
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Kane Biotech Announces Board Members
Jun 6, 2013
BC Pet Owners Have a New Weapon Against Dog Breath
May 22, 2013
Kane Biotech Appoints Distribution Partner for StrixNB(TM) Western Canada Launch
Mar 18, 2013
Kane Biotech Reports Successful Launch of StrixNB(TM)
Feb 21, 2013
Kane Biotech Announces Grant of Options and Extends Investor Relations Agreement
Feb 7, 2013
This Smile Brought To You By Science-StrixNB(TM)
Jan 31, 2013
Kane Biotech Announces Closing of Private Placement Offering
Dec 14, 2012
Kane Biotech Appoints Dr. Arvind K. Joshi, M.D. to the Board of Directors
Nov 28, 2012
Kane Biotech Receives Health Canada Approval for KBI Disinfectant Label Expansion
Nov 27, 2012
Kane Biotech Prepares to Launch StrixNB(TM) Pet Oral Care Product
Nov 20, 2012
1...
24
25
26
27
28
29
30
31
32
33
...38
